Shenzhen Hwagen Pharmaceutical

CAS 20054-45-9

Chemistry, 3 End Use API, 16 Related Intermediates

Manufacturers/Suppliers

3 Suppliers

3 Suppliers

Also known as: 20054-45-9, N-methyl-2-sulfanylbenzamide, 2-mercapto-n-methyl-benzamide, Benzamide, 2-mercapto-n-methyl-, N-methylthiosalicylamide, 2- mercapto-n-methyllbenzamide

Molecular Formula

C₈H₉NOS

Molecular Weight

167.23 g/mol

InChI Key

VIFOAZNEQRHREM-UHFFFAOYSA-N

1 2D Structure

CAS 20054-45-9

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

N-methyl-2-sulfanylbenzamide

2.1.2 InChI

InChI=1S/C8H9NOS/c1-9-8(10)6-4-2-3-5-7(6)11/h2-5,11H,1H3,(H,9,10)

2.1.3 InChI Key

VIFOAZNEQRHREM-UHFFFAOYSA-N

2.1.4 Canonical SMILES

CNC(=O)C1=CC=CC=C1S

2.2 Synonyms

2.2.1 Depositor-Supplied Synonyms

1. 20054-45-9

2. N-methyl-2-sulfanylbenzamide

3. 2-mercapto-n-methyl-benzamide

4. Benzamide, 2-mercapto-n-methyl-

5. N-methylthiosalicylamide

6. 2- Mercapto-n-methyllbenzamide

7. Ambz0056

8. Schembl2829218

9. Dtxsid10403947

10. Zinc397122

11. Bcp11862

12. Mfcd00136334

13. Akos000196042

14. Ac-26794

15. As-75577

16. Am20090683

17. Cs-0016511

18. Ft-0690189

19. F12015

20. 054m459

21. 3-(2-bromoacetyl)-5-chloro-n-(2-methoxyethyl)thiophene-2-sulfonamide

2.3 Create Date

2005-09-15

3 Chemical and Physical Properties

Molecular Formula	C₈H₉NOS
Molecular Weight	167.23 g/mol
XLogP3	2.1
Hydrogen Bond Donor Count	2
Hydrogen Bond Acceptor Count	2
Rotatable Bond Count	1
Exact Mass	167.04048508 g/mol
Monoisotopic Mass	167.04048508 g/mol
Topological Polar Surface Area	30.1 Å²
Heavy Atom Count	11
Formal Charge	0
Complexity	149
Isotope Atom Count	0
Defined Atom Stereocenter Count	0
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

List of Suppliers

Full Screen View

Reset Filter

Ask Us

Upload your Marketing & Sales content on your company Virtual Booth, click HERE

Post an Enquiry

China

Virtual Booth

Digital Content

6-Iodo-1H-indazole

PDF Supplier PDF

URL Supplier Web Content

CAS Number

261953-36-0

End Use API

Shenzhen HwaGen Pharmaceutical Co., Ltd. (HwaGen Pharma) was founded in December of 2015 under the leader...

Shenzhen HwaGen Pharmaceutical Co., Ltd. (HwaGen Pharma) was founded in December of 2015 under the leadership of a “National 1000 Talents Program” expert. By leveraging its core competency in chiral synthesis, enzymatic catalysis and continuous flow micro reactor, HwaGen Pharmaceutical is dedicated to development and manufacturing of specialty and niche intermediates and APIs covering various therapeutic areas including oncology, antiviral and respiratory, delivering high value-added and affordable products for global pharmaceutical industry. Equipments for Analysis & Test include Tabletop NMR, LC-MS, GC, HPLC etc.

ASK
US